GSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, ...

A Leicestershire pensioner with Parkinson's Disease died after becoming trapped by a safety belt designed to stop her falling ...

UK's health agency issued an alert after a blood pressure medicine was recalled amid misprinting error. Patients who consume the common blood pressure drug are being urged to monitor the medication ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) says some packs of lercanidipine, manufactured by Recordati Pharmaceuticals, have been wrongly labelled as containing 10mg tablets when ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Maine Democrats took a step toward constitutionalizing trans athletes' protections the day after the DOJ announced a lawsuit against the state over the issue.

Patients who take the common blood pressure medicine Lercanidipine HCI 20 mg tablets (lercanidipine hydrochloride) from the ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep.

The London-based pharmaceutical company said Blenrep, or belantamab mafodotin, was approved for the treatment of adult patients with multiple myeloma in combination with bortezomib plus dexamethasone, ...

More than 7,700 packs are affected by the recall, according to the Medicines and Healthcare products Regulatory Agency.

GSK (GSK) plc announced the authorization of Blenrep by the Medicines and Healthcare products Regulatory Agency. “In the UK, Blenrep is ...